Eszopiclone sleep medication recalled nationwide for shortfill packaging defect
Macleods Pharma USA Inc is recalling Eszopiclone 1 mg tablets due to shortfill—customers reported one to three missing tablets from 30-count bottles. Affected lot BEK2009A (exp. 11/2023) was distributed nationwide and to Puerto Rico.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a packaging defect (shortfill) with no reported illnesses, injuries, or hospitalizations. The hazard is insufficient quantity of product rather than a direct health or safety threat.
Plain-English summary
Macleods Pharma USA Inc has recalled Eszopiclone 1 mg tablets in 30-count bottles due to shortfill—a packaging defect where bottles contain fewer tablets than labeled. Customer complaints identified that affected bottles were missing one to three tablets.
The recalled lot is BEK2009A with an expiration date of November 2023. Approximately 168,690 tablets were distributed nationwide and to Puerto Rico. The product was manufactured by Macleods Pharmaceuticals Ltd. in Baddi, Himachal Pradesh, India, under NDC 33342-299-07.
Consumers who have bottles from the affected lot should contact their pharmacy or doctor with any questions. This is an FDA Class II recall.
The recalled product
- Product
- ESZOPICLONE (ESZOPICLONE)
- Brand
- ESZOPICLONE
- Manufacturer
- Macleods Pharma Usa Inc
- Category
- Drug — Prescription Sleep Aid
- Hazard
- shortfill
- packaging-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: BEK2009A Exp: 11/2023
UPCs (3)
- 0333342300119
- 0333342299079
- 0333342301116
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ESZOPICLONE
- LowEszopiclone Tablets Recalled for Failed Impurity and Degradation Specifications
FDA (Drugs) · 2024-07-10
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27